Hosted on MSN10m
10x Genomics (NASDAQ:TXG) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses ExpectationsRevenue: $165 million vs analyst estimates of $159.5 million (10.3% year-on ... enabling researchers to analyze biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback